Patients with SSBP1 mutations typically suffer from optic atrophy and have also been reported to experience neurological dysfunction mainly affecting the visual system (retinopathy, foveopathy, ptosis, ophthalmoplegia) and auditory system (sensorineural hearing loss) [46,162,163,164,165]. The gene discussed is SSBP1; the disease is optic atrophy.